FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study

CompletedOBSERVATIONAL
Enrollment

471

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Ovarian Cancer
Trial Locations (27)

1400

Research Site, México

3500

Research Site, Resistencia

5000

Research Site, Córdoba

5300

Research Site, La Rioja

C1118AAT

Research Site, Buenos Aires

C1431FWO

Research Site, Buenos Aires

C1426ANZ

Research Site, CABA

S2000KZE

Research Site, Rosario

14784-400

Research Site, Barretos

30130-100

Research Site, Belo Horizonte

81520-060

Research Site, Curitiba

60336-045

Research Site, Fortaleza

60430-230

Research Site, Fortaleza

17210-120

Research Site, Jaú

90610-000

Research Site, Porto Alegre

20560-120

Research Site, Rio de Janeiro

22793-080

Research Site, Rio de Janeiro

41950-610

Research Site, Salvador

01246-000

Research Site, São Paulo

01317-000

Research Site, São Paulo

Unknown

Research Site, Bogotá

Research Site, Medellín

Research Site, Santiago de Cali

Research Site, Panama City

Research Site, San Isidro

0051

Research Site, Lima

LIMA 11

Research Site, Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT02984423 - FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study | Biotech Hunter | Biotech Hunter